Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 1.55
TNDM's Cash to Debt is ranked lower than
58% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. TNDM: 1.55 )
Ranked among companies with meaningful Cash to Debt only.
TNDM' s Cash to Debt Range Over the Past 10 Years
Min: 0.53  Med: 3.26 Max: N/A
Current: 1.55
Equity to Asset 0.38
TNDM's Equity to Asset is ranked lower than
83% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. TNDM: 0.38 )
Ranked among companies with meaningful Equity to Asset only.
TNDM' s Equity to Asset Range Over the Past 10 Years
Min: -2.66  Med: 0.55 Max: 0.71
Current: 0.38
-2.66
0.71
F-Score: 4
Z-Score: -2.45
M-Score: -2.71
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -84.16
TNDM's Operating margin (%) is ranked lower than
77% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 2.65 vs. TNDM: -84.16 )
Ranked among companies with meaningful Operating margin (%) only.
TNDM' s Operating margin (%) Range Over the Past 10 Years
Min: -1335.27  Med: -161.30 Max: -94.72
Current: -84.16
-1335.27
-94.72
Net-margin (%) -88.95
TNDM's Net-margin (%) is ranked lower than
79% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. TNDM: -88.95 )
Ranked among companies with meaningful Net-margin (%) only.
TNDM' s Net-margin (%) Range Over the Past 10 Years
Min: -1333.94  Med: -188.81 Max: -99.41
Current: -88.95
-1333.94
-99.41
ROE (%) -96.71
TNDM's ROE (%) is ranked lower than
91% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. TNDM: -96.71 )
Ranked among companies with meaningful ROE (%) only.
TNDM' s ROE (%) Range Over the Past 10 Years
Min: -1331.34  Med: -122.70 Max: -93.5
Current: -96.71
-1331.34
-93.5
ROA (%) -53.44
TNDM's ROA (%) is ranked lower than
84% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: -0.01 vs. TNDM: -53.44 )
Ranked among companies with meaningful ROA (%) only.
TNDM' s ROA (%) Range Over the Past 10 Years
Min: -182.5  Med: -62.54 Max: -59.2
Current: -53.44
-182.5
-59.2
ROC (Joel Greenblatt) (%) -304.06
TNDM's ROC (Joel Greenblatt) (%) is ranked lower than
78% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 4.86 vs. TNDM: -304.06 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
TNDM' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -598.61  Med: -463.37 Max: -320.57
Current: -304.06
-598.61
-320.57
» TNDM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

TNDM Guru Trades in Q2 2015

Steven Cohen 1,175,000 sh (+193.68%)
Jim Simons 224,200 sh (+151.63%)
» More
Q3 2015

TNDM Guru Trades in Q3 2015

Steven Cohen 1,130,501 sh (-3.79%)
Jim Simons 138,829 sh (-38.08%)
» More
Q4 2015

TNDM Guru Trades in Q4 2015

Jim Simons 164,300 sh (+18.35%)
Steven Cohen 796,756 sh (-29.52%)
» More
Q1 2016

TNDM Guru Trades in Q1 2016

Jim Simons 239,300 sh (+45.65%)
Steven Cohen 825,000 sh (+3.54%)
John Paulson 540,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with TNDM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NAS:ELOS, NAS:RTIX, NAS:IRMD, OTCPK:VICA, NAS:AXGN, AMEX:CVRS, NAS:SURG, NAS:IRIX, OTCPK:XVIPF, NAS:FONR, NAS:EYES, OTCPK:VRAY, OTCPK:SOMNF, NAS:CUTR, NAS:ACRX, NYSE:GI, OTCPK:MHMNF, NAS:DRAD, OTCPK:IPDQF, NAS:SPNE » details
Traded in other countries:TD5.Germany,
Tandem Diabetes Care, Inc. is a medical device company engaged in the designing, development and commercialization of products for people with insulin-dependent diabetes. The Company's flagship product is the t:slim Insulin Delivery System.

Ratios

vs
industry
vs
history
P/B 5.14
TNDM's P/B is ranked lower than
69% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 2.95 vs. TNDM: 5.14 )
Ranked among companies with meaningful P/B only.
TNDM' s P/B Range Over the Past 10 Years
Min: 3.23  Med: 4.65 Max: 7.35
Current: 5.14
3.23
7.35
P/S 2.92
TNDM's P/S is ranked higher than
55% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 3.51 vs. TNDM: 2.92 )
Ranked among companies with meaningful P/S only.
TNDM' s P/S Range Over the Past 10 Years
Min: 0.22  Med: 3.31 Max: 6.32
Current: 2.92
0.22
6.32
EV-to-EBIT -3.21
TNDM's EV-to-EBIT is ranked lower than
99.99% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 22.17 vs. TNDM: -3.21 )
Ranked among companies with meaningful EV-to-EBIT only.
TNDM' s EV-to-EBIT Range Over the Past 10 Years
Min: -7.4  Med: -3.50 Max: 0.6
Current: -3.21
-7.4
0.6
EV-to-EBITDA -3.46
TNDM's EV-to-EBITDA is ranked lower than
99.99% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 18.09 vs. TNDM: -3.46 )
Ranked among companies with meaningful EV-to-EBITDA only.
TNDM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.8  Med: -3.70 Max: 0.6
Current: -3.46
-7.8
0.6
Current Ratio 4.13
TNDM's Current Ratio is ranked higher than
70% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.83 vs. TNDM: 4.13 )
Ranked among companies with meaningful Current Ratio only.
TNDM' s Current Ratio Range Over the Past 10 Years
Min: 1.63  Med: 5.02 Max: 10.21
Current: 4.13
1.63
10.21
Quick Ratio 3.32
TNDM's Quick Ratio is ranked higher than
71% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. TNDM: 3.32 )
Ranked among companies with meaningful Quick Ratio only.
TNDM' s Quick Ratio Range Over the Past 10 Years
Min: 1.26  Med: 4.36 Max: 9.5
Current: 3.32
1.26
9.5
Days Inventory 122.22
TNDM's Days Inventory is ranked higher than
54% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 134.88 vs. TNDM: 122.22 )
Ranked among companies with meaningful Days Inventory only.
TNDM' s Days Inventory Range Over the Past 10 Years
Min: 116.18  Med: 125.16 Max: 298.88
Current: 122.22
116.18
298.88
Days Sales Outstanding 41.18
TNDM's Days Sales Outstanding is ranked higher than
86% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 68.74 vs. TNDM: 41.18 )
Ranked among companies with meaningful Days Sales Outstanding only.
TNDM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.17  Med: 68.55 Max: 355.71
Current: 41.18
56.17
355.71
Days Payable 43.70
TNDM's Days Payable is ranked lower than
65% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 62.25 vs. TNDM: 43.70 )
Ranked among companies with meaningful Days Payable only.
TNDM' s Days Payable Range Over the Past 10 Years
Min: 20.64  Med: 39.44 Max: 161.64
Current: 43.7
20.64
161.64

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 8.46
TNDM's Price/Net Current Asset Value is ranked lower than
59% of the 249 Companies
in the Global Medical Devices industry.

( Industry Median: 7.14 vs. TNDM: 8.46 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
TNDM' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 4.35  Med: 5.93 Max: 9.47
Current: 8.46
4.35
9.47
Price/Tangible Book 5.37
TNDM's Price/Tangible Book is ranked lower than
59% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 4.19 vs. TNDM: 5.37 )
Ranked among companies with meaningful Price/Tangible Book only.
TNDM' s Price/Tangible Book Range Over the Past 10 Years
Min: 3.76  Med: 5.05 Max: 6.02
Current: 5.37
3.76
6.02
Price/Median PS Value 0.87
TNDM's Price/Median PS Value is ranked higher than
62% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. TNDM: 0.87 )
Ranked among companies with meaningful Price/Median PS Value only.
TNDM' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.08  Med: 1.07 Max: 1.79
Current: 0.87
0.08
1.79
Earnings Yield (Greenblatt) (%) -31.73
TNDM's Earnings Yield (Greenblatt) (%) is ranked lower than
84% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. TNDM: -31.73 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
TNDM' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -32.54  Med: 220.00 Max: 491.7
Current: -31.73
-32.54
491.7

More Statistics

Revenue (TTM) (Mil) $80.60
EPS (TTM) $ -2.38
Short Percentage of Float8.32%
52-Week Range $6.48 - 13.48
Shares Outstanding (Mil)30.35

Analyst Estimate


Warning: Invalid argument supplied for foreach() in /home/gurufocu/public_html/modules/stock/estimate.php on line 163
Dec16 Dec17 Dec18
Revenue (Mil $) 109 160 222
EPS ($) -2.17 -1.68 -0.61
EPS w/o NRI ($) -2.17 -1.68 -0.61
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for TNDM

Headlines

Articles On GuruFocus.com

More From Other Websites
Tandem Diabetes reports 2Q loss Jul 28 2016
Tandem Diabetes reports 2Q loss Jul 28 2016
Tandem Diabetes Care® Announces Expanded Pediatric Indication of t:slim® Insulin Pump for Ages 6... Jul 28 2016
Tandem Diabetes Care Reports Second Quarter 2016 Financial Results, Updates 2016 Guidance and... Jul 28 2016
4:16 pm Tandem Diabetes Care beats by $0.05, reports revs in-line; guides FY16 revs below consensus Jul 28 2016
TANDEM DIABETES CARE INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 28 2016
Tandem Diabetes Care Reports Second Quarter 2016 Financial Results, Updates 2016 Guidance and... Jul 28 2016
Q2 2016 Tandem Diabetes Care Inc Earnings Release - After Market Close Jul 28 2016
TANDEM DIABETES CARE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 26 2016
Tandem Diabetes Care® Announces Expanded Pediatric Indication of t:slim® Insulin Pump for Ages 6... Jul 26 2016
TANDEM DIABETES CARE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 21 2016
Tandem Diabetes Care and TypeZero Technologies Announce License Agreement to Accelerate Development... Jul 21 2016
ETF’s with exposure to Tandem Diabetes Care, Inc. : July 18, 2016 Jul 18 2016
Tandem Diabetes Care Schedules Second Quarter 2016 Earnings Press Release and Conference Call Jul 14 2016
Tandem Diabetes Care Schedules Second Quarter 2016 Earnings Press Release and Conference Call Jul 14 2016
Tandem Diabetes Care Gets FDA Approval For Remote Software Update Tool For Insulin Pumps Jul 14 2016
Tandem Diabetes Care Announces FDA Clearance of Remote Software Update Tool for Insulin Pumps Jul 14 2016
TANDEM DIABETES CARE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 14 2016
Tandem Diabetes Care Announces FDA Clearance of Remote Software Update Tool for Insulin Pumps Jul 14 2016
TANDEM DIABETES CARE INC Files SEC form 8-K, Entry into a Material Definitive Agreement Jul 01 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)